pharmaphorum
MAY 4, 2022
Testing drug compounds on a chip designed to mimic human organs sounds closer to science fiction than reality, yet the technology already exists and is already being put to use. Ben Hargreaves discovers how the technology could provide more accurate safety predictions and even discover new treatments. The limits of animal models in drug discovery are well known.
Outsourcing Pharma
MAY 4, 2022
CPhI North America 2022 host city Philadelphia is set to become one of the worldâs biggest cell and gene therapy manufacturing hubs. But itâs just one of many centers of innovation that are helping drive the US pharma and biopharma industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Impact Pharmaceutical Services
MAY 4, 2022
May 4, 2022 | Nathaniel DiTommaso, MS, Regulatory Affairs Manager. In May of 2014 and February of 2019 , the FDA released final Guidance for Industry outlining the Agency’s policies and procedures regarding expedited development and review programs for new drugs and biologics intended to treat serious or life-threatening conditions. Image courtesy of qimono at pixabay.com.
NF2 BioSolutions
MAY 4, 2022
Are you NF2 Aware? Get yourself selfie ready with our downloadable poster and SNAP! Send us your pictures or videos like this one! We have created a poster that you can print off, we would like everyone to get involved, take a selfie with the poster, or get someone else to take a photo of you and send it to us or post it onto your timeline (tag us please!).
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
MAY 3, 2022
Israeli cancer diagnosis startup Imagene AI has raised $21.5 million in first-round financing for its cancer diagnosis platform based digitised imaging of biopsy samples. The Series A – led by Oracle co-founder Larry Ellison and fellow investors Dr David Ahus and Zebra Medical Vision founder Eyal Gura – includes $3 million in seed funding from venture capital firm Blumberg Capital.
Outsourcing Pharma
MAY 5, 2022
According to the 2022 EY CEO survey, life science executives are seeking to build resilience into their supply chains and dive into M&A opportunities.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Board Vitals - Pharmacist
MAY 3, 2022
Happy Nurses Week 2022! During this week, which occurs annually on May 6-12, we take the time to recognize nurses and the impact they’ve made on the patient population. Many businesses offer discounts and freebies to show their support for nurses around the country. Here are some of the top Nurses Week promotions for 2022. . The below information was collected for Nurses Week 2022 and may include the previous year’s offers as some companies have not announced their offers as of publishing.
pharmaphorum
MAY 4, 2022
Cognitive problems affecting memory and attention can be substantial and long-lasting in patients who suffer severe COVID-19 infections, according to a study by researchers in the UK. The study used computerised cognitive assessments to follow-up 46 people who were hospitalised with COVID-19 at the Addenbrooke’s Hospital in Cambridge over a three-month period in 2020, comparing the results with 460 matched control subjects.
Outsourcing Pharma
MAY 4, 2022
An expert from Pharmatech Associates offers a glimpse into the evolution of CM and previews a lively discussion during the upcoming CPhI North America event.
Compounding Pharmacy of America
MAY 3, 2022
When a loved one is in hospice care, family members and caregivers need to make difficult, often emotional decisions. This often comes after an already-long road of supporting your loved one as they battle disease or through declining health. As a caregiver, you need to make sure your loved one is comfortable and getting everything […]. The post Loved Ones in Hospice Benefit From Compounding Meds appeared first on The Compounding Pharmacy of America.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Roots Analysis
MAY 3, 2022
Blue ocean strategy, a concept first introduced in 2004, by W Chan Kim, and Renee Mauborgne in their bestselling book of the same name, talks about how to achieve a breakthrough in a highly saturated market by focusing on creating a new uncontested market. Blue ocean strategy is a systematic approach that helps emerging service providers to create a new demand, rather than competing for an already existing demand.
pharmaphorum
MAY 3, 2022
Alain Labrique, PhD, professor and associate chair of research at Johns Hopkins Bloomberg School of Public Health (JHSPH) and chair of the World Health Organization (WHO) digital health guidelines development group discusses with us the ongoing research study, National Pandemic Pulse, he and his colleagues are performing in the US. Using comprehensive, repeat surveys deployed across the US population, Labrique and fellow researchers at JHSPH are measuring disparities and inequities due to COVID
Outsourcing Pharma
MAY 5, 2022
A leader from the clinical technology company discusses some of the pain points in data collection and analysis, and tools that can help users level up.
Pharma Marketing Network
MAY 2, 2022
Tune in and watch the Pharma Marketing network and industry experts from Otsuka, Biogen, Janssen Pharmaceuticals, and more during part 2 of a 2-part series on engagement. This PMN DTC Engagement Summit focused on DTC engagement throughout the following panels: Marketing at the Speed of Digital: Patient Engagement. Effective Use of Data in DTC Marketing.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Roots Analysis
MAY 2, 2022
In the past few years, plants have been gaining a rapid traction, involving genetic modification and expression of new genes in plant host cells. Owing to significant advantages over conventional expression systems, such as low production costs, product safety, and ease of scaling up, plants are being widely recognized as a potential platform for the development and manufacturing of wide range of biopharmaceuticals.
pharmaphorum
MAY 5, 2022
A quick recap: Who are CDISC and what do they do? The Clinical Data Interchange Standards Consortium (CDISC) is a non-profit organization that aims to maximise the impact of clinical research data by establishing and promoting the use of data standards. Basically, these standards make clinical data easier to understand and interpret. “We develop and advance data standards of the highest quality to transform incompatible formats, inconsistent methodologies, and diverse perspectives into a power
Outsourcing Pharma
MAY 5, 2022
This monthâs news on partnerships, appointments, expansions, and investment includes Javara, ACG, Phastar, Elligo Health Research, and other notable companies.
Pharma Times
MAY 6, 2022
WHO have stated that Veklury recommendation is being updated following compelling new evidence of hospital reductions
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Med Ed 101
MAY 4, 2022
As you may or may not be aware, Adderall and vitamin C can interact with each other. The primary issue for this drug interaction involves an alteration of Adderall’s gastrointestinal absorption. Having a more acidic gut environment can reduce the absorption of Adderall. Here’s my take on the Adderall vitamin C interaction and some questions […].
pharmaphorum
MAY 3, 2022
Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai. The new drug – Quviviq (daridorexant) – has been approved by the European Commission for adults who have been suffering insomnia for at least three months and are experiencing “considerable impact” on daytime functioning, according to the Swiss pharma company.
Outsourcing Pharma
MAY 4, 2022
An expert from the organization discusses ahead of his CPhI North America presentation how tomorrowâs drugs canât all be formulated with yesterdayâs excipients.
Pharma Times
MAY 5, 2022
DELIVER represents the largest ever trial to address heart failure with preserved ejection fraction
Med Ed 101
MAY 1, 2022
Working with a lot of geriatric patients, I run into patients complaining of dry eyes all the time. While many will readily admit that they have this issue, many will not even think to mention it because they have been dealing with it for a long time or they may consider it more of a […]. The post Patient Complains of Dry Eyes – What’s The Pharmacist’s Next Move?
pharmaphorum
MAY 6, 2022
Throughout my 30-year career, there have been many times it was obvious I stood out just because of my gender. I was often the only woman in the room, the meeting, or on the committee. Many colleagues had never worked with a woman leader before, let alone reported to a female boss. I’ve certainly faced barriers – sometimes literally. Exclusive behavior has many faces.
Outsourcing Pharma
MAY 4, 2022
A leader from the organizer of the pharmaceutical event discusses whatâs in store for the upcoming conference, and for the drug development industry itself.
Pharma Times
MAY 4, 2022
Platform will enable patients to monitor and share updates of their post-surgical wound healing
pharmaphorum
MAY 3, 2022
A scientist working in Switzerland has become the fifth person to be convicted of attempting to steal trade secrets from pharmaceutical group GlaxoSmithKline in a case that stretched back several years. Gongda Xue (52), a Chinese citizen formerly working at the Friedrich Miescher Institute for Biomedical Research in Switzerland, has been found guilty of conspiracy to steal trade secrets in relation to medicines under development at GSK between January 2010 and January 2016.
pharmaphorum
MAY 6, 2022
Sanofi has completed the spin-out of its pharma ingredients business EuroAPI, with shares in the new company rising more than 3% on its starting price of €12 in early trading on the Euronext exchange this morning in a declining market. The separation makes EuroAPI the world’s single largest producer of small-molecule active pharmaceutical ingredients (APIs) – and the second-largest API producer overall after Israel’s Teva – with a market valuation of more than $1.2 billion.
pharmaphorum
MAY 4, 2022
Hello Heart has raised $70 million in fourth-round financing to help grow its smartphone-based technology for people seeking to improve their heart health. Hello Heart blood pressure monitor. Hello Heart’s digital platform is based on a blood pressure monitor and smartphone app. It deploys artificial intelligence to help users track their blood pressure, pulse rate, weight and activity levels – as well as any medications taken – and give feedback and advice on how to adopt healthy practice
pharmaphorum
MAY 5, 2022
After a long period of not much change, clinical trials are undergoing several massive shifts. At the American Telemedicine Association conference in Boston this week, a Sunday afternoon panel explored the intersection of two of these changes: the growing use of telehealth in decentralised clinical trials, and an increased awareness of the importance of health equity and diversity in trials.
pharmaphorum
MAY 3, 2022
Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300 million upfront to access Dragonfly Therapeutics’ TriNKET platform to find therapies for cancer and inflammatory diseases. The deal initially focuses on preclinical-stage immunotherapy DF-7001 which targets 5T4, a protein found on cancer cells and stromal cells that is though to drive growth of various solid tumours, including non-small-cell lung cancer (NSCLC), breast cancer, pancreatic cancer a
pharmaphorum
MAY 6, 2022
A digital therapeutic (DTx) developed to help people suffering from insomnia has been shown to improve sleep and mental health in people recovering from a stroke in a clinical trial. The use of the Sleepio app improved sleep quality in 48% of patients enrolled into the study, which was conducted with the University of Oxford. The study found Sleepio users experienced less depression and anxiety after eight weeks follow-up, according to the results, which were presented this week at the European
pharmaphorum
MAY 6, 2022
Biogen has licensed rights to a digital therapeutic (DTx) developed by MedRhythms which combines sensors, software, and music to help people with multiple sclerosis tackle mobility problems. The biopharma company – which is one of the top players in MS drug therapies – is paying $3 million upfront to claim rights to the DTx, known as MR-004, and is also on the hook for an additional $117.5 million in development and commercial milestones plus royalties on any eventual sales.
Expert insights. Personalized for you.
143 
Let's personalize your content